Laura Sutcliffe
Stock Analyst at Citi
(3.10)
# 2,862
Out of 4,668 analysts
510
Total ratings
54%
Success rate
2.7%
Average return
Main Sectors:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $19.00 | $20.93 | -9.20% | 16 | Aug 21, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Hold | n/a | $43.12 | - | 8 | Aug 20, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $31.00 | $15.97 | +94.11% | 37 | Aug 20, 2026 | |
| ASX: COH Cochlear Limited | Upgraded: Hold | $100.00 → $140.00 | $136.24 | +2.76% | 17 | Aug 19, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $110.00 → $160.00 | $167.78 | -4.63% | 40 | Aug 19, 2026 | |
| NZE: EBO EBOS Group Limited | Maintained: Buy | $29.30 | $23.09 | +26.88% | 6 | Aug 18, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Hold | $34.00 → $33.00 | $32.15 | +2.64% | 22 | Aug 9, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $240.00 | $194.55 | +23.36% | 7 | Jul 15, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $42.00 | $45.40 | -7.48% | 16 | Jul 15, 2026 | |
| RMD ResMed | Downgraded: Hold | $270 → $235 | $228.44 | +2.87% | 14 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $36.00 → $33.50 | $35.21 | -4.86% | 15 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €40.00 → €34.00 | €24.34 | n/a | 14 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 86.00 → CHF 84.00 | CHF 126.34 | n/a | 61 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.21 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €118.00 → €103.00 | €77.79 | n/a | 56 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,850p → 1,820p | 1,921p | n/a | 85 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €95.00 → €87.00 | €217.65 | n/a | 16 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 2,880 → kr 2,600 | kr 2,141 | n/a | 16 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $33.41 | n/a | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $156.24 | n/a | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $390 | $1,038.12 | n/a | 1 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $88 → $90 | $28.27 | n/a | 5 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €108.00 | €138.05 | n/a | 1 | Feb 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $45.15 | n/a | 1 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $51.96 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $303 → $300 | $46.14 | n/a | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $96 → $99 | $1,244.40 | n/a | 18 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $55 | $65.47 | n/a | 16 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $143.44 | n/a | 14 | Oct 18, 2017 |
Sonic Healthcare Limited
Aug 21, 2026
Maintained: Hold
Price Target: $19.00
Current: $20.93
Upside: -9.20%
Fisher & Paykel Healthcare Corporation Limited
Aug 20, 2026
Maintained: Hold
Price Target: n/a
Current: $43.12
Upside: -
Telix Pharmaceuticals Limited
Aug 20, 2026
Maintained: Buy
Price Target: $31.00
Current: $15.97
Upside: +94.11%
Cochlear Limited
Aug 19, 2026
Upgraded: Hold
Price Target: $100.00 → $140.00
Current: $136.24
Upside: +2.76%
CSL Limited
Aug 19, 2026
Maintained: Hold
Price Target: $110.00 → $160.00
Current: $167.78
Upside: -4.63%
EBOS Group Limited
Aug 18, 2026
Maintained: Buy
Price Target: $29.30
Current: $23.09
Upside: +26.88%
ResMed Inc.
Aug 9, 2026
Maintained: Hold
Price Target: $34.00 → $33.00
Current: $32.15
Upside: +2.64%
Pro Medicus Limited
Jul 15, 2026
Maintained: Buy
Price Target: $240.00
Current: $194.55
Upside: +23.36%
Ramsay Health Care Limited
Jul 15, 2026
Maintained: Hold
Price Target: $42.00
Current: $45.40
Upside: -7.48%
ResMed
Jul 10, 2026
Downgraded: Hold
Price Target: $270 → $235
Current: $228.44
Upside: +2.87%
Jul 6, 2026
Maintained: Hold
Price Target: $36.00 → $33.50
Current: $35.21
Upside: -4.86%
May 7, 2024
Maintained: Hold
Price Target: €40.00 → €34.00
Current: €24.34
Upside: n/a
Dec 14, 2022
Maintained: Hold
Price Target: CHF 86.00 → CHF 84.00
Current: CHF 126.34
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: n/a
Current: $14.21
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: €118.00 → €103.00
Current: €77.79
Upside: n/a
Aug 8, 2022
Maintained: Hold
Price Target: 1,850p → 1,820p
Current: 1,921p
Upside: n/a
Jun 27, 2022
Maintained: Hold
Price Target: €95.00 → €87.00
Current: €217.65
Upside: n/a
May 20, 2022
Maintained: Buy
Price Target: kr 2,880 → kr 2,600
Current: kr 2,141
Upside: n/a
Mar 16, 2022
Upgraded: Buy
Price Target: n/a
Current: $33.41
Upside: n/a
Nov 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $156.24
Upside: n/a
Jun 18, 2021
Initiated Coverage: Buy
Price Target: $390
Current: $1,038.12
Upside: n/a
Apr 12, 2021
Maintained: Hold
Price Target: $88 → $90
Current: $28.27
Upside: n/a
Feb 28, 2020
Maintained: Hold
Price Target: €108.00
Current: €138.05
Upside: n/a
Aug 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $45.15
Upside: n/a
Feb 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $51.96
Upside: n/a
Aug 8, 2018
Maintained: Hold
Price Target: $303 → $300
Current: $46.14
Upside: n/a
Jul 25, 2018
Downgraded: Hold
Price Target: $96 → $99
Current: $1,244.40
Upside: n/a
Oct 26, 2017
Rated: Hold
Price Target: $55
Current: $65.47
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: $96
Current: $143.44
Upside: n/a